Sample pretreatment method for determining nanoscale cerium oxide in plasma or serum

A technology of sample pretreatment and nano-cerium oxide, which is applied in the direction of measuring devices, instruments, scientific instruments, etc., can solve the problems of increased test cost, complicated operation, unsuitable for large quantities of blood samples, etc., and achieves low reagent cost, simple process conditions, The effect of easy operation

Active Publication Date: 2020-05-19
上海药明康德新药开发有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But among them, the microwave digestion method requires a special microwave digestion system, and cannot digest dozens or even hundreds of samples at the same time, so it is not suitable for the digestion of large quantities of blood samples; the main disadvantage of the enzymatic hydrolysis method is the need to control the amount of enzyme added and the time of enzymatic hydrolysis , enzymatic hydrolysis temperature and other related process conditions, the operation is more complicated, and special protease needs to be purchased, resulting in increased test costs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sample pretreatment method for determining nanoscale cerium oxide in plasma or serum
  • Sample pretreatment method for determining nanoscale cerium oxide in plasma or serum
  • Sample pretreatment method for determining nanoscale cerium oxide in plasma or serum

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] a. Uniform distribution of nano-cerium oxide particles: nano-cerium oxide particles containing 0.1% HNO 3 Dissolve with a mixed aqueous solution of 0.1% Triton-X-100, vortex with a vortex instrument, and configure a storage solution. Take stock solution to contain 0.1% HNO 3 Dilute with a mixed aqueous solution of 0.1% Triton-X-100 to prepare a working solution, mix the working solution with a plasma or serum matrix in proportion, vortex with a vortex instrument, and configure a mixed matrix solution containing nano-cerium oxide particles. A certain amount of HNO was added to the blank matrix 3 And Triton-X-100 as a reference substance.

[0026] b. Nano cerium oxide particle reducing agent addition treatment: take 60 microliters of the mixed matrix solution and add it to a 10 milliliter polypropylene centrifuge tube, then add 20 microliters of internal standard solution, then add 300 microliters of concentrated nitric acid, add 50 microliters Hydrogen peroxide, vorte...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a sample pre-treatment device for determining nano-grade cerium oxide in blood plasma or blood serum by adopting an inductively coupled plasma mass spectrometer. The sample pre-treatment device comprises the following steps: step 1, uniformly distributing nano-grade cerium oxide particles; step 2, adding a reduction agent into the nano-grade cerium oxide particles; step 3, digesting blood plasma protein or blood serum protein and carrying out reduction treatment on the cerium oxide particles; step 4, carrying out post-treatment. According to the sample pre-treatment device disclosed by the invention, a stock and working solution is prepared by adopting a mixed solution of nitric acid and Triton-X-100 and the nano-grade cerium oxide particles stably exist in the solution; a manner of digesting in a water bath at 80 DEG C for one night is adopted and the blood plasma protein or the blood serum protein is digested to reduce cerium oxide into trivalent cerium ions, so that accurate detection of an inductively coupled plasma mass spectrum can be carried out. According to the sample pre-treatment device disclosed by the invention, a nano-grade cerium oxide particle solution is stable and the protein is completely digested; a method is simple to operate and the testing cost is low; the determination of a large batch of blood plasma samples can be realized in one step.

Description

technical field [0001] The invention relates to a sample processing method, in particular to a sample pretreatment method for measuring nanoscale cerium oxide in plasma or serum by using an inductively coupled plasma mass spectrometer. Background technique [0002] Cerium oxide is a rare earth oxide. Nano-sized cerium oxide has the function of removing free radicals in the human body and preventing the spread of cancer cells. It has great medicinal value in medicine. [0003] In 2013, when Wason MS et al. conducted a study on mice inoculated with human pancreatic cancer cells, they found that nano-cerium oxide particles were beneficial to the scavenging of superoxide free radicals, and that nano-cerium oxide was used in the radiotherapy matrix before pancreatic cancer in mice. Can significantly reduce the cancer cells in the culture medium and tumors and protect normal cells. The results show that nano-cerium oxide may become a novel photosensitizer for the treatment of pan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N27/62
CPCG01N27/62
Inventor 王波梁文忠蒋华芳张欣焦凯生张雪高舜龙
Owner 上海药明康德新药开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products